IL157777A0 - Method to prepare microparticles that contain metoprolol - Google Patents

Method to prepare microparticles that contain metoprolol

Info

Publication number
IL157777A0
IL157777A0 IL15777702A IL15777702A IL157777A0 IL 157777 A0 IL157777 A0 IL 157777A0 IL 15777702 A IL15777702 A IL 15777702A IL 15777702 A IL15777702 A IL 15777702A IL 157777 A0 IL157777 A0 IL 157777A0
Authority
IL
Israel
Prior art keywords
metoprolol
contain
prepare microparticles
microparticles
contain metoprolol
Prior art date
Application number
IL15777702A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IL157777A0 publication Critical patent/IL157777A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
IL15777702A 2001-03-09 2002-03-06 Method to prepare microparticles that contain metoprolol IL157777A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0100824A SE0100824D0 (sv) 2001-03-09 2001-03-09 Method III to obtain microparticles
PCT/SE2002/000401 WO2002072074A1 (en) 2001-03-09 2002-03-06 Method to prepare microparticles metoprolol that contain

Publications (1)

Publication Number Publication Date
IL157777A0 true IL157777A0 (en) 2004-03-28

Family

ID=20283295

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15777702A IL157777A0 (en) 2001-03-09 2002-03-06 Method to prepare microparticles that contain metoprolol

Country Status (24)

Country Link
US (1) US20040116392A1 (enExample)
EP (1) EP1370245B1 (enExample)
JP (1) JP2004522798A (enExample)
KR (1) KR20030081507A (enExample)
CN (1) CN1236761C (enExample)
AT (1) ATE295153T1 (enExample)
AU (1) AU2002235102B2 (enExample)
BR (1) BR0207919A (enExample)
CA (1) CA2440167A1 (enExample)
DE (1) DE60204125T2 (enExample)
ES (1) ES2240691T3 (enExample)
HU (1) HUP0303450A2 (enExample)
IL (1) IL157777A0 (enExample)
IS (1) IS6937A (enExample)
MX (1) MXPA03008088A (enExample)
NO (1) NO20033967L (enExample)
NZ (1) NZ528168A (enExample)
PL (1) PL363972A1 (enExample)
PT (1) PT1370245E (enExample)
RU (1) RU2292878C2 (enExample)
SE (1) SE0100824D0 (enExample)
UA (1) UA75909C2 (enExample)
WO (1) WO2002072074A1 (enExample)
ZA (1) ZA200306880B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100823D0 (sv) * 2001-03-09 2001-03-09 Astrazeneca Ab Method I to obtain microparticles
US20060159756A1 (en) * 1999-09-10 2006-07-20 Brita Sjoblom Method to obtain microparticles containing an H+,K+-ATP-ASE inhibitor
SE0100822D0 (sv) * 2001-03-09 2001-03-09 Astrazeneca Ab Method II to obtain microparticles
US8006685B2 (en) * 2002-07-05 2011-08-30 Turbochef Technologies, Inc. Re-circulating oven with gas clean-up
EP1915137B8 (de) 2005-08-10 2013-09-11 ADD Advanced Drug Delivery Technologies, Ltd. Orales präparat mit kontrollierter freisetzung
US20070053983A1 (en) * 2005-09-06 2007-03-08 Girish Jain Extended release compositions of metoprolol succinate
NZ574427A (en) * 2006-07-28 2011-11-25 Zaklady Farmaceutyczne Polpharma S A Extended release pharmaceutical formulation of metoprolol and process for its preparation
ES2753148T3 (es) * 2007-02-23 2020-04-07 Glatt Air Techniques Inc Método para determinar el peso del recubrimiento que va a ser aplicado para formar una forma de dosificación de liberación controlada
CN101269056B (zh) * 2007-03-19 2010-05-19 天津药物研究院 一种美托洛尔盐类口服脉冲微丸制剂
NZ584521A (en) * 2007-10-10 2011-03-31 Avantor Performance Mat Inc Directly compressible high functionality granular microcrystalline cellulose based excipient, manufacturing process and use thereof
US20100055180A1 (en) * 2007-10-10 2010-03-04 Mallinckrodt Baker, Inc. Directly Compressible Granular Microcrystalline Cellulose Based Excipient, Manufacturing Process and Use Thereof
CN102641257A (zh) * 2012-03-31 2012-08-22 内蒙古医学院 阿替洛尔缓释微囊及其制备方法
RU2585023C1 (ru) * 2014-12-18 2016-05-27 Общество с ограниченной ответственностью "Нанолек" Способ гранулирования
CN104739805B (zh) * 2015-04-09 2017-12-19 邸蓉 制备琥珀酸美托洛尔缓释微丸的复相乳液法
WO2019183470A2 (en) 2018-03-22 2019-09-26 Incarda Therapeutics, Inc. A novel method to slow ventricular rate
CN115252913A (zh) * 2022-08-02 2022-11-01 赛诺神畅医疗科技有限公司 一种血管给药涂层及其制备方法和应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US653014A (en) * 1899-10-06 1900-07-03 Ashley & Bailey Company Process of silkifying cotton.
SE354851B (enExample) * 1970-02-18 1973-03-26 Haessle Ab
SE418247B (sv) * 1975-11-17 1981-05-18 Haessle Ab Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
DE3565475D1 (en) * 1984-04-07 1988-11-17 Bayer Ag Process and apparatus for the production of granules
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
SE450087B (sv) * 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
DE3909455A1 (de) * 1989-03-22 1990-09-27 Hoechst Ag Verfahren zur herstellung von wasserdispergierbaren granulaten
FR2725623A1 (fr) * 1994-10-18 1996-04-19 Flamel Tech Sa Microcapsules medicamenteuses et/ou nutritionnelles pour administration per os
AU6824996A (en) * 1995-08-17 1997-03-12 Dyer, Alison Margaret Controlled release products
DE19613395A1 (de) * 1996-04-03 1997-10-09 Basf Ag Granulate hygroskopischer, wasserlöslicher Produkte
US6096339A (en) * 1997-04-04 2000-08-01 Alza Corporation Dosage form, process of making and using same
US5891474A (en) * 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
DE19733094A1 (de) * 1997-07-31 1999-02-04 Merck Patent Gmbh Formulierung auf der Basis von Ascorbinsäure mit verbesserter Farbstabilität
WO1999018935A1 (de) * 1997-10-15 1999-04-22 Merck Patent Gmbh Herstellung eines direkt verpressbaren tablettierhilfsstoffes
EP0987020A1 (en) * 1998-09-04 2000-03-22 Pharma Pass LLC Metoprolol composition and processes for manufacturing the same
US6395300B1 (en) * 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
US20060159756A1 (en) * 1999-09-10 2006-07-20 Brita Sjoblom Method to obtain microparticles containing an H+,K+-ATP-ASE inhibitor
SE0100823D0 (sv) * 2001-03-09 2001-03-09 Astrazeneca Ab Method I to obtain microparticles
TWI354568B (en) * 2000-09-20 2011-12-21 Jagotec Ag Insoluble drug particle compositions with improved
SE0100822D0 (sv) * 2001-03-09 2001-03-09 Astrazeneca Ab Method II to obtain microparticles

Also Published As

Publication number Publication date
DE60204125T2 (de) 2006-01-19
ATE295153T1 (de) 2005-05-15
ZA200306880B (en) 2004-12-03
JP2004522798A (ja) 2004-07-29
PT1370245E (pt) 2005-08-31
EP1370245A1 (en) 2003-12-17
ES2240691T3 (es) 2005-10-16
IS6937A (is) 2003-09-03
NO20033967L (no) 2003-10-28
RU2292878C2 (ru) 2007-02-10
EP1370245B1 (en) 2005-05-11
NO20033967D0 (no) 2003-09-08
NZ528168A (en) 2005-01-28
DE60204125D1 (de) 2005-06-16
BR0207919A (pt) 2004-04-27
UA75909C2 (en) 2006-06-15
US20040116392A1 (en) 2004-06-17
MXPA03008088A (es) 2003-12-12
HK1059737A1 (en) 2004-07-16
CN1507345A (zh) 2004-06-23
SE0100824D0 (sv) 2001-03-09
PL363972A1 (en) 2004-11-29
HUP0303450A2 (hu) 2004-01-28
CA2440167A1 (en) 2002-09-19
AU2002235102B2 (en) 2006-08-31
RU2003127739A (ru) 2005-03-10
KR20030081507A (ko) 2003-10-17
WO2002072074A1 (en) 2002-09-19
CN1236761C (zh) 2006-01-18

Similar Documents

Publication Publication Date Title
IL157777A0 (en) Method to prepare microparticles that contain metoprolol
MXPA03007887A (es) Metodo para obtener microparticulas que contienen inhibidor de h(+), k(+)-atp-asa.
HUT68689A (en) Alpha-heteroaryloxymethyl-ketones as interleukin-1-beta converting enzyme inhibitors, pharmaceutical compositions containing them, process for producing them and the compositions
HUP0204399A3 (en) Pteridine compounds for the treatment of psoriasis, process for their preparation, pharmaceutical compositions containing them and their use
IL103282A0 (en) Substituted 4-alkoxypyrimidines,process for their preparation,compositions containing them,and their use as pesticides
CA2425005A1 (en) Process for preparing powder formulations
MY134222A (en) NEW MEDICAMENT COMPOSITIONS BASED ON ANTICHOLINERGICALLY-EFFECTIVE COMPOUNDS AND ß-MIMETICS
MX9805016A (es) INHIBIDORES DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1 beta.
MY136231A (en) Slow release compositions
IL157846A0 (en) Stable astaxanthin-containing powdery compositions and process for producing the same
MX9602442A (es) Un tratamiento con fluoroquinolona a dosis unica elevada.
BG104436A (en) The administration of macrolides for the treatment of cancer and macular degeneration
HUP0003641A3 (en) Dibenzocycloheptene derivatives as vitronectin receptor antagonists, process for producing them and pharmaceutical compositions containing them
PL348728A1 (en) Method and apparatus in a fluidized bed reactor
ES2124669A1 (es) Material de radiacion infrarrojo extrema y medicina y alimento derivados del mismo.
HUP0201785A3 (en) Dihydrobenzodiazepins, process for producing them, their use and pharmaceutical compositions containing them
AU2003249327A8 (en) Process for sonicating plant seeds
IL165086A (en) Pyridyl cyanoguanidines, pharmaceutical compositions comprising them and uses thereof for the preparation of medicaments
AU2003213661A8 (en) Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders
HUT67599A (en) Process for producing dry- processed particles, the produced dry-processed particles, and pharmaceutical compositions containing them
HUP9702481A3 (en) New n-benzylpiperazine compounds, process for producing them and the pharmaceutical compositions which containing them
HU9801925D0 (en) Sodium-hydrogen-change-inhibitors for producing pharmaceutical compositions for treating diseases caused by protozoons
GB9702081D0 (en) Process for preparing colloidal calcium carbonte by particle sizer
EP1206524A4 (en) METHODS OF GENERATING DUAL HAPLOID PLANTS
ZA929909B (en) Agricultural use of certain compounds, compositions and methods for producing said compounds.